ישראל - עברית - Ministry of Health

תרו אינטרנשיונל בע"מ - sebclair is indicated to manage and relief the itching, burning, scaling and pain experienced with seborrhoic dermatitis.

ישראל - עברית - Ministry of Health

תרו אינטרנשיונל בע"מ - sebclair is indicated as treatment of the disease of the scalp (seborrheic dermatitis, pityriasis versicolor) and anti-dandruff treatment

ישראל - עברית - Ministry of Health

"כצט בע""מ" - כלל האוכלוסיה - ספריי להקלה על כאבים הנובעים מפצעים ואפטות בחלל הפה

ישראל - עברית - Ministry of Health

rafa laboratories ltd. - כלל האוכלוסיה - ג'ל אוראלי

ישראל - עברית - Ministry of Health

rafa laboratories ltd. - כלל האוכלוסיה - ג'ל אוראלי

ישראל - עברית - Ministry of Health

surpass medical ltd. - רופא - the aneurysm-embolization system is indicated for use for the treatment of saccular, or fusiform intracranial aneurysms arising from a parent vessel with a diameter of ?2 mm and ?6 mm.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליות לעיסות - montelukast as sodium 5 mg - montelukast - montelukast - singulair 5 mg is indicated in adult and pediatric patients 6 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליה - montelukast as sodium 10 mg - montelukast - montelukast - singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.

ישראל - עברית - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליות לעיסות - montelukast as sodium 4 mg - montelukast - montelukast - singulair is indicated in pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction.singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled carticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - montelukast as sodium 4 mg - granules - montelukast - singulair is indicated in adult and pediatric patients 12 months of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treament of aspirin - sensitive asthmatic patients, and the prevention of exercise - induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitatly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability.